Cargando…
Estrogen receptor β suppresses inflammation and the progression of prostate cancer
Previous studies demonstrated that estrogen receptor β (ERβ) signaling alleviates systemic inflammation in animal models, and suggested that ERβ-selective agonists may deactivate microglia and suppress T cell activity via downregulation of nuclear factor κ-light-chain-enhancer of activated B cells (...
Autores principales: | Xiao, Long, Luo, Yaohui, Tai, Rongfen, Zhang, Ningnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472045/ https://www.ncbi.nlm.nih.gov/pubmed/30864712 http://dx.doi.org/10.3892/mmr.2019.10014 |
Ejemplares similares
-
Involvement of estrogen receptor β in androgen receptor-induced growth inhibition in prostate cancer PC-3 cells
por: Xiao, Long, et al.
Publicado: (2017) -
Estrogen receptor β exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity
por: Chaurasiya, Surendra, et al.
Publicado: (2020) -
MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-β signaling in estrogen receptor positive breast cancer cells
por: Yin, Kai, et al.
Publicado: (2016) -
Estrogen Inhibits Renal Cell Carcinoma Cell Progression through Estrogen Receptor-β Activation
por: Yu, Cheng-Ping, et al.
Publicado: (2013) -
Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis
por: Yang, Yang, et al.
Publicado: (2022)